'Babylab’ uses pioneering technology to help children suffering from ADHD

Posted on September 22, 2015

Research has begun at Birkbeck Babylab, University of London, involving 10-month-olds who have an elder sibling or family member already diagnosed with ADHD or autism.

Children found to be displaying symptoms of ADHD will be given non-invasive therapies that aim to improve concentration and attention — “rewiring the brain” and saving them years of dependence on drugs such as Ritalin to control the condition.

The Babylab trial is the first to combine eye-tracking technology — which measures levels of attention — with new academic theories on ADHD.

Researchers hope the three-year project will help identify an “early-warning system” for ADHD and establish whether early interventions can reduce its severity and extent.